Tirzepatide is a dual GLP-1 and GIP receptor agonist delivered through a once-weekly injection
Definition Box Glycosaminoglycans (GAGs): Long, unbranched polysaccharides (including hyaluronic acid, chondroitin sulfate, and dermatan sulfate) that hydrate the extracellular matrix and support tissue elasticity and structural cohesion
1998 CJC-1295 preserves pulsatile GH secretion while increasing basal levels 7.5-fold
Weeks 12 through 24 allow for progressive loading: increasing resistance in strength training, adding moderate-intensity cardio, and returning to pre-pregnancy activities as tolerated
Clinical Update 3/04/2022 Protein Shake for Weight Management
Eli Lilly, the company behind tirzepatide, recently received FDA approval for an oral GLP-1 medicine called orforglipron